Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesEarnAISquareMore
HM Revenue & Customs sends crypto gains tax "reminder" letters to about 65,000 crypto investors in the UK

HM Revenue & Customs sends crypto gains tax "reminder" letters to about 65,000 crypto investors in the UK

ForesightNewsForesightNews2025/10/19 01:52
Show original

Foresight News reported, according to the Financial Times, that the UK's HM Revenue & Customs (HMRC) is intensifying its scrutiny of crypto investors, with the number of warning letters sent to individuals suspected of underreporting or evading taxes on digital asset gains having doubled. In the 2024–25 fiscal year, nearly 65,000 such letters were issued, compared to just 27,700 in the previous year. These letters, known as "nudge" letters, are intended to encourage investors to voluntarily correct their tax filings before a formal investigation is launched. Over the past four years, the agency has sent out more than 100,000 such letters.

0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

Hypertension drug developer Retension (RTSN.US) applies for US listing, plans to raise $58 million.

U.S. hypertension drug developer Retension Pharmaceuticals filed documents with the SEC last Friday, planning to raise up to $58 million through an initial public offering (IPO).

智通财经2026/09/21 07:11

Pfizer (PFE.US) overseas price increase gains to be shared with the U.S. government: "Most Favored Nation" contract revealed, over twenty transactions still confidential

According to reports, under a new contract with the U.S. Department of Health and Human Services, Pfizer will share higher overseas drug revenues with the United States.

智通财经2026/09/21 07:11

Autoimmune and inflammatory disease pharmaceutical company TRex Bio (TRX.US) applies for US listing, plans to raise up to 100 millions dollars.

TRex Bio filed documents with the U.S. Securities and Exchange Commission (SEC) last Friday, intending to raise up to 100 million USD through an initial public offering (IPO).

智通财经2026/09/21 07:11